Kyn Therapeutics

1030 Massachusetts Avenue
Suite 400
United States

Show jobs for this employer

About Kyn Therapeutics

Kyn Therapeutics is building a new generation of immuno-oncology therapies targeting powerful immunosuppressive metabolic networks. We envision a future where immunotherapies are the foundation of every cancer patient's treatment, delivering rapid and durable responses.

The Kyn team is composed of drug hunters, translational researchers and entrepreneurs drawn from many of the largest innovators in biotechnology supported by world-class advisors, and is backed by a seasoned board of directors anchored by OrbiMed Healthcare Fund Management and Atlas Venture.

Kyn Therapeutics is headquartered in the biotech hub of Cambridge, Massachusetts.


President and CEO: Mark Manfredi, PhD
VP, R&D: Michelle Zhang, PhD
VP, Drug Discovery: Karen McGovern, PhD
SVP, Chemistry and Preclinical Development: Alfredo Castro PhD
SVP, R&D: Jeffrey Ecsedy, PhD
Head of CMC Operations: James Nolan

Please click here for Kyn Therapeutics' pipeline

8 articles with Kyn Therapeutics